University of Missouri-Kansas City and Saint Luke’s Mid America Heart Institute researchers have been selected to receive two prestigious, highly competitive research awards from the Patient-Centered Outcomes Research Institute (PCORI). The studies are part of a portfolio of projects designed to help patients make better-informed decisions about their care. The combined awards total $3,562,032.
John Spertus, MD, MPH, Lauer/Missouri Endowed Chair at the UMKC School of Medicine and Clinical Director of Outcomes Research at Saint Luke’s Mid America Heart Institute, and Adnan Chhatriwalla, MD, an interventional cardiologist at Saint Luke’s Mid America Heart Institute, were awarded $1,725,651 to develop and test a personalized, shared decision-making tool for doctors and patients to discuss options in percutaneous coronary intervention (PCI) or angioplasty, a commonly performed procedure to open blocked arteries in the heart and improve blood flow using a stent, or wire-mesh tube. This project will involve numerous patients in the community in its design, and be implemented at Saint Luke’s and Truman Medical Center to help improve Jackson County residents’ engagement in care.
Kim Smoldren, PhD, a previous research fellow at Saint Luke’s, and Spertus were awarded $1,836,381 to study patient-centered outcomes recovery from treating peripheral arterial disease (PAD), blockages in arteries in the lower extremities. The study, designed with input from residents of Jackson County on the structure and outcomes of the project, will enroll patients from eight cities throughout the U.S., including Saint Luke’s and Truman Medical Center. It will provide invaluable insights into how to better care for PAD patients in the future.
“This is the type of translational research that is a priority for the School of Medicine and our community,” said Betty Drees, dean of the UMKC School of Medicine. “Dr. Spertus’ research award will work toward positioning the physician to choose the best treatment based on the individual patient, which is the meaning of personalized medicine.”
Patient outcomes research is a major aspect of the proposed Jackson County Institute for Translational Medicine, on the ballot Nov. 5. The initiative is a partnership among UMKC, Children’s Mercy, Kansas City Area Life Sciences Institute and Saint Luke’s Health System. UMKC would receive about $8 million annually for 20 years for research that delivers personalized medicine to the young and aging, and works to solve health disparities in minority populations.